COMMUNIQUÉS West-GlobeNewswire

-
Nexstim Plc appoints Sisu Partners as new Certified Adviser
23/04/2018 - 16:01 -
Tabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call on Tuesday, May 8, 2018
23/04/2018 - 16:00 -
Novo Nordisk A/S: Share repurchase programme
23/04/2018 - 15:54 -
Immuron’s Travelan® Sales Continue to Soar in Third Quarter of FY2018 in Australian & US Markets
23/04/2018 - 15:30 -
UPDATE -- Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting
23/04/2018 - 15:29 -
Sienna Senior Living Announces Redemption of Extendible Convertible Unsecured Subordinated Debentures
23/04/2018 - 15:00 -
OrthoPediatrics Corp. to Report First Quarter 2018 Financial Results on May 14, 2018
23/04/2018 - 15:00 -
AXIM Biotech Secures Additional Funding to Advance Cannabidnoid-Based Clinical Development Program for Multiple Indications
23/04/2018 - 15:00 -
Ceapro Inc. Provides Corporate Update
23/04/2018 - 15:00 -
Progyny Launches Two How-To Guides to Support Employers and their Employees as they Navigate Infertility in the Workplace
23/04/2018 - 15:00 -
Vous avez le feu vert pour sauver des vies : Semaine nationale de sensibilisation au don d’organes et de tissus (22-28 avril)
23/04/2018 - 15:00 -
You have the green light to save a life: April 22-28 is National Organ and Tissue Donation Awareness Week
23/04/2018 - 15:00 -
Abba Medix Receives its License to Produce Cannabis Oil
23/04/2018 - 14:57 -
Wildflower Completes Acquisition of Retail and Cultivation Licenses in LA
23/04/2018 - 14:50 -
AzurRx BioPharma and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II in Exocrine Pancreatic Insufficiency (EPI)
23/04/2018 - 14:45 -
Sarepta Therapeutics to Announce First Quarter 2018 Financial Results and Recent Corporate Developments on May 3, 2018
23/04/2018 - 14:30 -
Ultragenyx Announces Filing and FDA Clearance of an Investigational New Drug Application for DTX401, a Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia
23/04/2018 - 14:30 -
Vystar Acquires Assets of NHS Holdings
23/04/2018 - 14:30 -
Sarepta Therapeutics to Announce First Quarter 2018 Financial Results and Recent Corporate Devel-opments on May 3, 2018
23/04/2018 - 14:30
Pages